Numerous analysts have said the GLP-1s are very likely to disrupt certain areas of the MedTech industry, while others say MedTech can live side-by-side with the weight-loss drugs
10.1016/j.jad.2015.03.058 72
Maximum: 14 mg once daily, if 7 mg dose is insufficient Possible side effects include: Gastrointestinal: nausea, vomiting, diarrhea The long-term safety of GLP-1 receptor agonists has not yet been established
Patients should respond promptly to defecation urges rather than delaying, as postponement can lead to progressive stool hardening and more difficult evacuation
For product-specific navigation, the Synjardy listing can help you identify the relevant medication page without replacing medical review
Moreover, we discuss cutting-edge tools that are revolutionizing resistance research, including single-cell and spatial multiomic profiling, patient-derived tumor organoid and xenograft (PDO/PDX) models, and artificial intelligence (AI)-powered predictive analytics